Siren, L.L.C. Lexicon Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 38,918,903 shares of LXRX stock, worth $43.6 Million. This represents 1.9% of its overall portfolio holdings.
Number of Shares
38,918,903
Previous 38,918,903
-0.0%
Holding current value
$43.6 Million
Previous $17.9 Billion
105.23%
% of portfolio
1.9%
Previous 1.01%
Shares
3 transactions
Others Institutions Holding LXRX
# of Institutions
130Shares Held
226MCall Options Held
431KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$153 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$11.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.85MShares$9.91 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$5.13 Million0.03% of portfolio
-
Sessa Capital Im, L.P. New York, NY3MShares$3.36 Million0.09% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $211M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...